Amfenac Sodium Salt (CAS 61618-27-7)

Amfenac Sodium Salt is extensively used in scientific studies focused on understanding the biochemistry of inflammatory processes. This chemical acts primarily as a nonsteroidal anti-inflammatory drug (NSAID) by selectively inhibiting cyclooxygenase (COX), an enzyme pivotal for the synthesis of prostaglandins, which are key mediators of inflammation. Research utilizing Amfenac Sodium Salt delves into the molecular pathways of COX inhibition, particularly examining its selectivity towards COX-2 over COX-1, which provides insights into the enzyme′s role in cellular responses to inflammatory stimuli. This specificity makes Amfenac an excellent tool for dissecting the role of prostaglandins in various biological processes, such as cell signaling and inflammation-induced gene expression. Studies often employ this compound in biochemical assays to explore its impact on prostaglandin levels within different cellular models, including its effects on prostaglandin-driven pathways that regulate pain signaling in neurons. Additionally, Amfenac Sodium Salt is used in comparative analyses of NSAID efficacy, helping to chart the landscape of enzyme inhibition and its downstream effects on cell behavior. This research contributes broadly to the fundamental understanding of cellular response mechanisms underpinning inflammation.